Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.15p
   
  • Change Today:
    -0.25p
  • 52 Week High: 4.35
  • 52 Week Low: 2.35
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,303,808
  • Market Cap: £16.80m
  • Beta: 0.01

Eden Research product granted temporary approval in Greece

By Josh White

Date: Monday 02 Sep 2024

LONDON (ShareCast) - (Sharecast News) - Sustainable biopesticide developer Eden Research announced on Monday that its Cedroz product has been granted temporary approval in Greece for the 2024 growing season.
The AIM-traded firm said the approval, in accordance with EU Regulation 1107/2009, allowed Cedroz to be used on potatoes to combat wireworms.

Cedroz, distributed in Greece by Eastman Chemical - Eden's commercial partner in several countries - would provide farmers with a new tool to protect potato crops from wireworms.

The pests, which are the larvae of click beetles, cause significant damage to potatoes by creating holes and tunnels, leading to reduced crop quality and yield.

Eden said the increasing prevalence of wireworms had left farmers with limited options, most of which rely on synthetic insecticides.

With an estimated 5,000 to 6,000 hectares of potato fields in Greece affected by wireworms, it said Cedroz presented a substantial commercial opportunity beyond its established role as a nematicide in horticultural crops.

"The granting of this temporary approval indicates that there are no other commercially available, viable alternatives to Cedroz for this particular use," said chief executive officer Sean Smith.

"We have seen in previous trials, and even under a previously granted temporary approval in Italy on wireworms, that the product works well and, as such, we are confident that there is a strong business case for this use."

At 1147 BST, shares in Eden Research were up 6.1% at 4.35p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.15p
Change Today -0.25p
% Change -7.35 %
52 Week High 4.35
52 Week Low 2.35
Volume 1,303,808
Shares Issued 533.35m
Market Cap £16.80m
Beta 0.01

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average
Price Trend
56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average
22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average
Income Not Available
Growth
55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eden Research Dividends

No dividends found

Trades for 21-Aug-2025

Time Volume / Share Price
15:07 36,405 @ 3.17p
14:00 1,000 @ 3.48p
14:00 1,000 @ 3.48p
12:44 51,532 @ 3.20p
10:30 431,207 @ 3.10p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page